Pars Capital Partners, LLC. is an independent advisory firm focused on the CRO and CDMO subsectors. Pars clients include:

  • Companies providing support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis
  • Financial sponsors holding platform position and pursuing bolt-on strategy
  • Financial sponsors looking to establish a position within the served subsector

Independent M&A advisory firm focused on serving clients operating in the CRO and CDMO subsectors

  • Mergers
  • Acquisitions
  • Divestitures
  • Analysis of private and public companies
  • Identifying acquisition targets
  • Identifying stretigic buyer
  • ​Identifying financial buye

Research & Analysis

Research & Analysis
The subsectors which we operate in are extremely fragmented. Beyond the handful of public companies in our operating subsectors, and a few larger private companies that file material information with the Securities Exchange Commission, reliable data is difficult to secure.

Majority of operating companies in the subsector have a revenue base of below $25 million, and there are no absolute sources in the market identifying these companies.

Due to the single focus of Pars Capital on the subsectors of CRO and CDMO, we have one of the most comprehensive databases of the companies operating the space.


Pars Capital Partners, LLC © ALL RIGHTS RESERVED. 

Pars provides research and analysis on the fragmented CRO and CDMO subsectors


Pars Capital provides BUY and SELL Side transactional services to its clients

Pars Capital Partners, LLC is an intermediary firm focused on transaction and research services within the CRO and CDMO subsectors